MAIA
MAIA Biotechnology Inc.
NYSE MKT: MAIA · HEALTHCARE · BIOTECHNOLOGY
$1.30
+4.00% today
Updated 2026-04-29
Market cap
$75.23M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.70
Dividend yield
—
52W range
$1 – $3
Volume
0.9M
MAIA Biotechnology Inc. (MAIA) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
-2.1%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+57.3%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-2.0%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-2.6%
2025-11-04
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-23 | $-0.14 | -5.2% | $1.46 | $1.44 | -1.4% |
| 2025-11-04 | $-0.27 | -42.1% | $1.16 | $1.13 | -2.6% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.13 | $-0.14 | -5.2% | — | — |
| 2025-09-30 | $-0.19 | $-0.27 | -42.1% | — | — |
| 2025-06-30 | $-0.25 | $-0.18 | +28.0% | — | — |
| 2025-03-31 | $-0.18 | $-0.16 | +11.1% | — | — |
| 2024-12-31 | $-0.35 | $-0.32 | +8.6% | — | — |
| 2024-09-30 | $-0.47 | $-0.36 | +24.5% | — | — |
| 2024-06-30 | $-0.42 | $-0.50 | -20.5% | — | — |
| 2024-03-31 | $-0.39 | $-0.46 | -17.9% | — | — |
| 2023-12-31 | $-0.39 | $-0.40 | -2.6% | — | — |
| 2023-09-30 | $-0.38 | $-0.36 | +5.3% | — | — |
| 2023-06-30 | $-0.38 | $-0.35 | +7.9% | — | — |
| 2023-03-31 | $-0.40 | $-0.38 | +5.0% | — | — |
Frequently asked questions
Has MAIA Biotechnology Inc. beaten earnings estimates?
MAIA Biotechnology Inc. has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of -2.1% over the last 4 quarters.
How does MAIA stock react to earnings?
MAIA stock has moved an average of -2.0% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.